Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
139.1 USD | +2.72% | -0.20% | +6.41% |
May. 31 | Neurocrine Biosciences Insider Sold Shares Worth $5,338,565, According to a Recent SEC Filing | MT |
May. 28 | Neurocrine Biosciences Says CEO Kevin Gorman Retiring | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+6.41% | 13.63B | |
+15.44% | 118B | |
+13.74% | 106B | |
-2.35% | 24.28B | |
+1.14% | 21.96B | |
-9.35% | 18.16B | |
-42.28% | 16.37B | |
-16.68% | 15.56B | |
+29.11% | 12.27B | |
+86.72% | 8.87B |
- Stock Market
- Equities
- NBIX Stock
- News Neurocrine Biosciences, Inc.
- Neurocrine Biosciences Insider Sold Shares Worth $297,860, According to a Recent SEC Filing